Proteome Sciences (LON:PRM) Announces Quarterly Earnings Results

Proteome Sciences (LON:PRM) announced its quarterly earnings data on Thursday. The company reported GBX (1.15) (($0.01)) earnings per share for the quarter, Digital Look Earnings reports. Proteome Sciences had a negative net margin of 0.04% and a negative return on equity of 0.01%.

Proteome Sciences Stock Down 11.0 %

LON:PRM opened at GBX 3.16 ($0.04) on Thursday. The firm has a market capitalization of £9.33 million, a PE ratio of -2.29 and a beta of 0.07. The stock has a 50 day moving average of GBX 4.08 and a 200-day moving average of GBX 3.46. Proteome Sciences has a 52 week low of GBX 2.22 ($0.03) and a 52 week high of GBX 5.40 ($0.07). The company has a current ratio of 0.20, a quick ratio of 0.37 and a debt-to-equity ratio of -258.66.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.